SCHEMBL29706186

SCHEMBL29706186

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ RAMP3 O60896 8/20 0.51
▸ CALCR P30988 8/20 0.51
▸ CXCR4 P61073 1/20 0.51
▸ KDM1A O60341 2/20 0.49
▸ MAOB P27338 1/20 0.49
▸ KDM5A P29375 1/20 0.49
▸ KDM1B Q8NB78 1/20 0.49
▸ CAPN1 P07384 2/20 0.48
▸ NPY2R P49146 5/20 0.48
▸ NPY4R P50391 5/20 0.48
▸ NPY5R Q15761 5/20 0.48
▸ NPY1R P25929 3/20 0.48
▸ MAPK8 P45983 1/20 0.48
▸ MAPK9 P45984 1/20 0.48
▸ MAPK10 P53779 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30185743 0.90 KDM1A (0.53) RAMP3CALCRCXCR4KDM1AMAOB
SCHEMBL12237948 0.87 CXCR4 (0.49) RAMP3CALCRCXCR4CAPN1MAPK8
SCHEMBL31277208 0.87 OPRM1 (0.51) RAMP3CALCRCXCR4KDM1AMAOB
SCHEMBL29982489 0.87 KDM1A (0.53) RAMP3CALCRCXCR4KDM1AMAOB
SCHEMBL30185756 0.87 RAMP3 (0.56) RAMP3CALCRKDM1ANPY2RNPY4R
SCHEMBL30432923 0.86 RAMP3 (0.53) RAMP3CALCRCAPN1NPY2RNPY4R
SCHEMBL31474426 0.86 RAMP3 (0.61) RAMP3CALCRCXCR4KDM1AMAOB
SCHEMBL29679604 0.86 RAMP3 (0.57) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL30571126 0.86 RAMP3 (0.54) RAMP3CALCRKDM1AMAOBKDM5A
SCHEMBL29680011 0.86 RAMP3 (0.56) RAMP3CALCRKDM1AMAOBKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230416329-A1 A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-12-28 — — US disclosed
CN-116615436-A Disulfide bond-containing polypeptide with serine protease activity inhibiting function, hybrid peptide derived from disulfide bond-containing polypeptide and application of disulfide bond-containing polypeptide 中国医学科学院药物研究所 2023-08-18 — — CN disclosed
WO-2022111713-A9 POLYPEPTIDE CONTAINING DISULFIDE BONDS AND CAPABLE OF INHIBITING ACTIVITY OF SERINE PROTEASE, DERIVED HYBRID PEPTIDE THEREOF, AND USE THEREOF 中国医学科学院药物研究所 2023-07-27 — — WO disclosed
CN-114573686-A Polypeptide containing disulfide bond and having serine protease activity inhibition function and application thereof 中国医学科学院药物研究所 2022-06-03 — — CN disclosed
WO-2022111713-A1 POLYPEPTIDE CONTAINING DISULFIDE BONDS AND CAPABLE OF INHIBITING ACTIVITY OF SERINE PROTEASE, DERIVED HYBRID PEPTIDE THEREOF, AND USE THEREOF 中国医学科学院药物研究所 2022-06-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416329-A1 A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF VIP, SI, TMPRSS15 RAMP3 2728/4885CALCR 2656/4885CXCR4 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback